Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-22-041608

Options or other derivatives

  • Director acquired 26,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Erck Stanley C Director 2022-06-29 Grant or award · Stock Option (right to buy) +26,900 26,900 D
Loading xslF345X03/doc4.xml…